Detalhe da pesquisa
1.
Magnetic Resonance Imaging of Iron Metabolism with T2* Mapping Predicts an Enhanced Clinical Response to Pharmacologic Ascorbate in Patients with GBM.
Clin Cancer Res
; 30(2): 283-293, 2024 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37773633
2.
Magnetic resonance imaging (MRI) of pharmacological ascorbate-induced iron redox state as a biomarker in subjects undergoing radio-chemotherapy.
Redox Biol
; 38: 101804, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33260088
3.
First-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed Glioblastoma.
Clin Cancer Res
; 25(22): 6590-6597, 2019 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31427282
4.
Pharmacologic Ascorbate Reduces Radiation-Induced Normal Tissue Toxicity and Enhances Tumor Radiosensitization in Pancreatic Cancer.
Cancer Res
; 78(24): 6838-6851, 2018 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30254147
5.
Consuming a Ketogenic Diet while Receiving Radiation and Chemotherapy for Locally Advanced Lung Cancer and Pancreatic Cancer: The University of Iowa Experience of Two Phase 1 Clinical Trials.
Radiat Res
; 187(6): 743-754, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28437190
6.
O2â - and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate.
Cancer Cell
; 31(4): 487-500.e8, 2017 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28366679
7.
O2â - and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate.
Cancer Cell
; 32(2): 268, 2017 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28810149